We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
59 result(s) found, displaying 11 to 20
-
Cancellation by sponsorRequested by ViiV Healthcare Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CABENUVA cabotegravir 400 mg/2 mL plus rilpivirine 600 mg/2 mL prolonged-release suspensions for injection vials.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VOCABRIA cabotegravir (as sodium) 30 mg film-coated tablet, bottle.
-
Prescription medicine registrationActive ingredients: cabotegravir sodium, cabotegravir.
-
Australian public assessment report (AusPar)TIVICAY (dolutegravir ) for treatment of HIV infection in combination with other antiretroviral agents.
-
Cancellation by sponsorRequested by ViiV Healthcare Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Fostemsavir trometamol
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TIVICAY dolutegravir (as sodium) 25 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TIVICAY dolutegravir (as sodium) 10 mg film-coated tablet bottle.